Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases
Clinical trial NCT01763385 · UNKNOWN
Trial details
- NCT number
- NCT01763385
- Sponsor
- Wu Jieping Medical Foundation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2016-05-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.